Yang X, Ong H, Dickmander R, Smith J, Brown J, Tao W
ACS Omega. 2023; 8(42):39546-39561.
PMID: 37901516
PMC: 10600890.
DOI: 10.1021/acsomega.3c05377.
Lant A
J R Coll Physicians Lond. 2019; 2(3):298-309.
PMID: 30667783
PMC: 5370717.
Goldring R, Cannon P, Heinemann H, Fishman A
J Clin Invest. 1968; 47(1):188-202.
PMID: 16695940
PMC: 297159.
DOI: 10.1172/JCI105708.
EDEL H, EIGLER J, Renner E
Klin Wochenschr. 1966; 44(8):421-4.
PMID: 5986557
DOI: 10.1007/BF01727453.
Dirks J, CIRKSENA W, BERLINER R
J Clin Invest. 1966; 45(12):1875-85.
PMID: 5926633
PMC: 292873.
DOI: 10.1172/JCI105492.
Ethacrynic acid: two years' experience with a new diuretic.
LEDINGHAM J, BAYLISS R
Br Med J. 1965; 2(5464):732-5.
PMID: 5825410
PMC: 1846203.
DOI: 10.1136/bmj.2.5464.732.
Frusemide in heart failure of infancy.
Richardson H
Arch Dis Child. 1971; 46(248):520-4.
PMID: 5565464
PMC: 1647783.
DOI: 10.1136/adc.46.248.520.
[Renal hemodynamics, electrolyte excretion and acid-base equilibrium in an acute human experiment with ethacrynic acid].
KRECKE H, Klein H, Uhse H, KRUCK F
Klin Wochenschr. 1971; 49(7):397-405.
PMID: 5550635
DOI: 10.1007/BF01484995.
[The effectivness of ethacrynic acid, amiloride HCl and aldadiene K in kidney insufficiency].
QUELLHORST E, Scheler F
Klin Wochenschr. 1970; 48(8):471-80.
PMID: 5519400
DOI: 10.1007/BF01485097.
Clinical trial of mefruside, a new diuretic.
AULD W, MURDOCH W
Br Med J. 1971; 4(5790):786-8.
PMID: 5135250
PMC: 1799712.
DOI: 10.1136/bmj.4.5790.786.
Diuretics. II. Clinical considerations.
ANDERTON J, Kincaid-Smith P
Drugs. 1971; 1(2):141-65.
PMID: 4939014
DOI: 10.2165/00003495-197101020-00003.
Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.
Levine D, Ramsay L, Auty R, Branch R, Tidd M
Eur J Clin Pharmacol. 1976; 09(5-6):381-6.
PMID: 786663
DOI: 10.1007/BF00606552.
